Sun PharmaceuticalsDilip ShanghviRanbaxyDaiichi SankyoSuzlon

SPARC To Sell Priority Review Voucher For $195 Mn

SPARC To Sell Priority Review Voucher For $195 Mn

BY PTI

Dilip Sanghvi, Executive Chairman, Sun Pharma

Sun Pharma's Shanghvi and His $11.75 Bn Masterstroke

BY Shristi Acharya

Sun Pharmaceuticals

Sun Pharma Shares Rally 9% after $11.75 Bn Organon Acquisition

BY Outlook Business Desk

Sun Pharma–Organon Deal: Where Does It Rank in the List of Outgoing Acquisitions?

Sun Pharma–Organon Deal: Where Does It Rank in the List of Outgoing Acquisitions?

BY Outlook Business Desk

Sun Pharma’s Mega Buyout Plan: Inside $13 Bn Organon Cash Deal Structure

Sun Pharma's $13 Billion Organon Deal: How It's Structured

BY Outlook Business Desk

Sun Pharma Moves Closer to $12 Bn Organon Acquisition, Banks Line Up Financing

Sun Pharma Nears $12 Bn Organon Takeover

BY Outlook Business Desk

Sun Pharma Partners With Royal Challengers Bengaluru As Principal Sponsor For 3-Year Period

Sun Pharma Partners With Royal Challengers Bengaluru As Principal Sponsor For 3-Year Period

BY PTI

Advertisement

Sun Pharma Shares Climb Nearly 4% Post Earnings Announcement

Sun Pharma Shares Climb Nearly 4% Post Earnings Announcement

BY PTI

Sun Pharma, Cipla Recall Products in US Market: USFDA

Sun Pharma, Cipla Recall Products in US Market: USFDA

BY PTI

Sun Pharma Gets DCGI Nod For Generic Weight-Loss Drug Amid Patent Fight With Novo Nordisk

Sun Pharma Gets DCGI Nod For Generic Weight-Loss Drug

BY Outlook Business Desk

Sun Pharma Gets DCGI Nod to Market Generic Semaglutide Injection

Sun Pharma Gets DCGI Nod to Market Generic Semaglutide Injection

BY PTI

Sun Pharmaceutical Reopens Talks With Organon, Eyes Historic $10 Bn Overseas Pharma Deal

Sun Pharma Likely to Buy Organon for $10 Bn

BY Outlook Business Desk

Sun Pharma Arm Recalls over 17K Units of Antifungal Shampoo in US

Sun Pharma Arm Recalls over 17K Units of Antifungal Shampoo in US: USFDA

BY PTI

Sun Pharma Gets OAI Classification from USFDA for Baska Facility

Sun Pharma Gets OAI Classification for Baska Facility

BY PTI

Advertisement

After Dr Reddy’s, Sun Pharma Gets Court Nod to Export Weight-Loss Drug

Sun Pharma Allowed to Export Semaglutide Like Dr Reddy's

BY Outlook Business Desk

Sun Pharma

Sun Pharma Launches Plaque Psoriasis Drug ILUMYA in India

BY PTI

LinkedIn/@Sun Pharmaceuticals : Sun Pharmaceutical Industries

Sun Pharma Elevates Kirti Ganorkar as MD; Shanghvi to Continue as Executive Chairman

BY PTI

Gautam Adani, Mukesh Ambani Among Billionaires Hit by Stock Market Slump| Full List Here

Gautam Adani, Mukesh Ambani Among Billionaires Hit by Stock Market Slump| Full List Here

BY Outlook Business Desk

Sun Pharma to Acquire Checkpoint Therapeutics Inc for Up to $355 Million

Sun Pharma to Acquire Checkpoint Therapeutics Inc for Up to $355 Million

BY PTI

Sun Pharma Q2 Net Profit Rises 28 Per cent to Rs 3,040 Crore

Sun Pharma Q2 Net Profit Rises 28 Per cent to Rs 3,040 Crore

BY PTI

Sun Pharma To Acquire Remaining 21.52% Shares Of Taro For Rs 2,892 Crore

Sun Pharma To Acquire Remaining 21.52% Shares Of Taro For Rs 2,892 Crore

BY Press Trust of India

Advertisement

USFDA Pulls Up Sun Pharma For Lapses In Halol Plant

Sun Pharma Q2 Net Up 5% At Rs 2,375 Cr

BY Press Trust of India

Sun Pharma Q3 Profit

Sun Pharma Q3 Profit At Rs 2,166 Crore

BY Press Trust of India

Sun Pharmaceutical Launches Phenobarbital Sodium Injection In US

Sun Pharmaceutical Launches Phenobarbital Sodium Injection In US

BY Press Trust of India

Sun Pharmas Halol Facility Listed Under USFDA Import Alert

Sun Pharma's Halol Facility Listed Under USFDA Import Alert

BY Press Trust of India

Sensex.

Markets Settle With Modest Gains In Highly Volatile Trade

BY Press Trust of India

Sun Pharmaceuticals - A Specialty player

Sun Pharmaceuticals - A Specialty player